GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Human Metabolome Technologies Inc (TSE:6090) » Definitions » 5-Year Yield-on-Cost %

Human Metabolome Technologies (TSE:6090) 5-Year Yield-on-Cost % : 3.93 (As of Jul. 19, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Human Metabolome Technologies 5-Year Yield-on-Cost %?

Human Metabolome Technologies's yield on cost for the quarter that ended in Dec. 2024 was 3.93.


The historical rank and industry rank for Human Metabolome Technologies's 5-Year Yield-on-Cost % or its related term are showing as below:

TSE:6090' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.32   Med: 1.83   Max: 3.99
Current: 3.93


During the past 11 years, Human Metabolome Technologies's highest Yield on Cost was 3.99. The lowest was 1.32. And the median was 1.83.


TSE:6090's 5-Year Yield-on-Cost % is ranked better than
71.87% of 64 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.935 vs TSE:6090: 3.93

Competitive Comparison of Human Metabolome Technologies's 5-Year Yield-on-Cost %

For the Diagnostics & Research subindustry, Human Metabolome Technologies's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Human Metabolome Technologies's 5-Year Yield-on-Cost % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Human Metabolome Technologies's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Human Metabolome Technologies's 5-Year Yield-on-Cost % falls into.


;
;

Human Metabolome Technologies 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Human Metabolome Technologies is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Human Metabolome Technologies  (TSE:6090) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Human Metabolome Technologies 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Human Metabolome Technologies's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Human Metabolome Technologies Business Description

Traded in Other Exchanges
N/A
Address
Yamagata Prefecture Kakuganji Water 246-2, Tsuruoka, JPN, 997-0052
Human Metabolome Technologies Inc is involved in the search and diagnosis of biomarkers and commercialization in the field of drug development.

Human Metabolome Technologies Headlines

No Headlines